Protective role of metallothionein in renal toxicity of cisplatinum
暂无分享,去创建一个
[1] J. Lazo,et al. Metallothionein null cells have increased sensitivity to anticancer drugs. , 1995, Cancer research.
[2] J. Lazo,et al. Enhanced Sensitivity to Oxidative Stress in Cultured Embryonic Cells from Transgenic Mice Deficient in Metallothionein I and II Genes (*) , 1995, The Journal of Biological Chemistry.
[3] R. Palmiter,et al. Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[4] A. Michalska,et al. Targeting and germ-line transmission of a null mutation at the metallothionein I and II loci in mouse. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[5] A. Naganuma,et al. Modulation of both cisplatin nephrotoxicity and drug resistance in murine bladder tumor by controlling metallothionein synthesis. , 1993, Cancer research.
[6] M Sato,et al. Oxygen free radicals and metallothionein. , 1993, Free radical biology & medicine.
[7] N. Saijo,et al. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin. , 1991, Cancer research.
[8] G. Mulder,et al. The role of metallothionein in the reduction of cisplatin-induced nephrotoxicity by Bi3(+)-pretreatment in the rat in vivo and in vitro. Are antioxidant properties of metallothionein more relevant than platinum binding? , 1991, Biochemical pharmacology.
[9] A. Naganuma,et al. Protection against cisplatin toxicity by administration of glutathione ester 1 , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[10] J. Lazo,et al. A hypothesis regarding the protective role of metallothioneins against the toxicity of DNA interactive anticancer drugs. , 1990, Toxicology letters.
[11] E. Thorling,et al. Can bismuth decrease the kidney toxic effect of cis-platinum? , 1989, European journal of cancer & clinical oncology.
[12] H. Amano,et al. [The pharmacokinetics of cisplatin and its influence on renal function according to different infusion methods (report II)--alleviation of renal impairment by bismuth subnitrate combined with ginseng and tang-koui ten]. , 1989, Gan to kagaku ryoho. Cancer & chemotherapy.
[13] A. Schäffer,et al. Biochemistry of metallothionein. , 1988, Biochemistry.
[14] J. Hannemann,et al. Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex: different effects of antioxidants and radical scavengers. , 1988, Toxicology.
[15] A. Naganuma,et al. Prevention of lethal and renal toxicity of cis-diamminedichloroplatinum(II) by induction of metallothionein synthesis without compromising its antitumor activity in mice. , 1987, Cancer research.
[16] S. D. Murphy,et al. Effect of diethylmaleate and other glutathione depletors on protein synthesis. , 1986, Biochemical pharmacology.
[17] Koyama Yuko,et al. Protective effect of metallothionein inducing metals on lethal toxicity of cis-diamminedichloroplatinum in mice. , 1985 .
[18] J. Hoeschele,et al. In vivo and in vitro binding of platinum to metallothionein. , 1984, Archives of biochemistry and biophysics.
[19] I. Edwards,et al. cis-Platinum: subcellular distribution and binding to cytosolic ligands. , 1983, Biochemical pharmacology.
[20] F. Zunino,et al. Protective Effect of Reduced Glutathione against CIS-Dichlorodiammine Platinum (II)–Induced Nephrotoxicity and Lethal Toxicity , 1983, Tumori.
[21] J. Trosko,et al. Platinum Compounds: a New Class of Potent Antitumour Agents , 1969, Nature.
[22] G. Ellman,et al. Tissue sulfhydryl groups. , 1959, Archives of biochemistry and biophysics.
[23] A. Naganuma,et al. Protection against lethal toxicity of various anticancer drugs by preinduction of metallothionein synthesis in mice , 1993 .
[24] C. Merrin. Treatment of genitourinary tumours with cis-dichlorodiammineplatinum(II): experience in 250 patients. , 1979, Cancer treatment reports.
[25] J. Harrington,et al. Platinum nephrotoxicity. , 1978, The American journal of medicine.